AADAT and in situ carcinoma: However, the combination of NAC + CIS significantly reduced KATII activity compared to control and CIS groups (26 ± 4 pmoles/h/mg protein vs. 61 ± 12 or 83 ± 15.2 pmoles/h/mg protein, respectively).